feed,title,long_url,short_url
Benzinga,Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial,https://benzinga.com/general/biotech/21/12/24458605/ocular-therapeutixs-dexamethasone-ophthalmic-insert-meets-primary-goal-in-dry-eye-disease-trial,https://j.mp/3osBTfX
Benzinga,Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients,https://benzinga.com/general/biotech/21/12/24458315/immunocore-immtac-candidate-shows-early-response-in-ovarian-and-head-neck-cancer-patients,https://j.mp/3pzzZcu
